This is a protocol for a Campbell Evidence and Gap Map. The objectives are to identify and assess the available evidence on health, social care and technological interventions to improve functional ability among older adults.
Verdes
. While many nations are becoming wealthy with the influx of global socioeconomic developments, many countries, especially low-and middle income countries, have experienced increasing health and social disparities, especially among older adults (WHO, 2015) . Older adults with the greatest health needs are also often those with the fewest resources to support them (Beard et al., 2016) . For example, older adults in low-and middle income countries have poor access to assistive technologies and medical devices, as a result of a confluence of factors that affect the availability of these products in local markets including affordability and appropriateness, which can influence their availability, accessibility, and integration into health and social systems (Garçon et al., 2016; Marasinghe, Lapitan, & Ross, 2015) . Furthermore, the privatization of health and social services becomes a barrier to quality of care if costs impact access to appropriate and timely care for older adults. Functional ability is complex and comprises an individual's intrinsic capacity and people's interaction with their environment, including environmental characteristics that enable people to be and do what they value (Cesari et al., 2018; WHO, 2015) .
The WHO considers intrinsic capacity to include the physical and mental capacities of a person. Likewise, the environment defined by the WHO includes all factors in the extrinsic world that form the context of an individual's life. For example, the home, community and society are included alongside the built environment, interpersonal relationships, attitudes, values, health and social policies, and the systems that support individuals and services (WHO, 2015) .The Priority Assistive Products List of essential assistive devices that includes wheelchairs, pill organizers, hearing aids, and other essential items for many older people and people with disabilities to be able to live a healthy and dignified life and mitigate declines in intrinsic capacity (World, 2016) .
The accumulation of exposures and environmental influences throughout the life course can influence the development of different risk factors that lead to chronic diseases, injuries, or other age-related issues that contribute to declines in intrinsic capacities. Without a supportive environment, whether social or built, this will result in diminished functional ability. The gradual decline in intrinsic capacities as some people age can require increased health and social care services from informal (i.e., family or friends) and formal caregivers (i.e., health professionals). Increased care needs lead to increased burden on families, stress for older adults, and costs to society. For this reason, efforts to deliver cost efficient, effective interventions that optimize functional ability at any level of intrinsic capacity, is critical for older adults. Health and social care interventions (including assistive health technologies), and related systems, services and policies may include technological tools and devices and provision of health and social supports in the home.
While it is important to offer home-based supports that promote functional ability, we need to be mindful that existing health inequities may be worsened Gottlieb & Alderwick, 2019) . For example, if health and social services are provided privately and not covered by the health system or health insurance, all individuals will not have the same opportunities to achieve optimal health. Furthermore, the diagnosis, management and treatment of chronic health conditions in older adults can be prone to age-based, unconscious bias and explicit discrimination, which can lead to less than optimal care (Cherubini, Corsonello, & Lattanzio, 2012; Drury, Abrams, Swift Hannah, Lamont Ruth, & Gerocova, 2017) . Likewise, age-based bias is seen in research on conditions that affect older adults such as stroke and osteoarthritis, with the median age of participants over 10 years younger than the typical patient (Gaynor, Geoghegan, & O'Neill, 2014; Liberopoulos, Trikalinos Nikolaos, & Ioannidis John, 2009 (Chalmers & Glasziou, 2009) , some of which could be avoided by prioritizing research, including rigorous evaluation of existing evidence using systematic reviews (SR) prior to funding or carrying out new research (Chalmers et al., 2014) . An evidence and gap maps (EGM) is a decision making and research prioritization tool that highlights gaps in research to inform strategic health and social policy, program and research priorities (Snilstveit, Vojtkova, Bhavsar, & Gaarder, 2013) .
EGMs can be used to avoid needless duplication, and can also be used to identify where sufficient, high quality evidence from systematic reviews and randomized trials are available as a basis for decisions or where sufficient studies are available for knowledge synthesis (Snilstveit, Vojtkova, Bhavsar, Stevenson, & Gaarder, 2016) .
This EGM is important to inform policy and research prioritization. ageing. The WHO aims to meet these by implementing evidence-based actions to maximize functional ability of every individual (World, 2016) .
In this way the process of "optimizing opportunities for health, participation and security will enhance the quality of life as people age" (WHO, 2015) . This EGM is relevant to the first objectivea commitment to action on healthy ageing in every country. Furthermore, our objectives align with the United Nations Sustainable Development Goals and the objectives of the UN High Level meeting on preventing and controlling non-communicable diseases (United, 2018 (United, , 2019 .
We will take a health systems perspective to extend the focus from health care to include social care and technological interventions. The evidence will be presented in terms of functional ability. We will also consider determinants of health inequity. The proposed EGM will consider the multi-faceted and complex nature of functional ability and the various mechanisms (e.g., services, products, and individuals) involved in supporting functional ability among ageing adults.
We have a broad range of intended user groups including practitioners, researchers, policy/decision-makers, and the public.
We have also included three stakeholder groups as authors and advisory members: the WHO Department of Ageing and Life Course (RS), Cochrane Global Ageing (JTC) and the Campbell Ageing group (JTC). Each of these intended users are included as authors on the EGM and have participated in defining the intervention and outcome framework. The EGM will be used to identify the best quality evidence to guide decision making in this area. It will also help to identify gaps in the evidence base both in terms of evidence syntheses and primary research and thereby facilitate the prioritization of topics for further research.
Currently, no EGMs exist that identify and assess the available evidence on health, social care, and technological interventions to improve functional ability among older adults.
| OBJECTIVES
The objectives are to:
• Identify available systematic reviews and randomized trials.
• Identify areas where systematic reviews are needed.
• Identify gaps in evidence where further primary research is needed.
• Assess equity considerations in available systematic reviews and randomized trials.
• Assess gaps and evidence related to health equity.
| METHODS

| Evidence and gap map: definition and purpose
We will adapt evidence gap map methods from various key papers (Bragge et al., 2011; Lum, Koper Christopher, & Telep Cody, 2011; Snilstveit et al., 2013 Snilstveit et al., , 2016 and will adopt a fivestage process:
• Define a framework.
• Identify the available evidence.
• Appraise the quality of the evidence.
• Extract, code and summarize the data that relate to the objectives.
• Visualization and presentation of the findings in a user-friendly manner.
We will use the Campbell Collaboration mapping tool developed by the EPPI-Centre (Eppi-Centre, 2019) to display identified studies using the framework described below.
| Framework development and scope
The framework was developed following a meeting with methodologists, practitioners, decision-makers and consumers at the Cochrane Colloquium during the 2017 Global Evidence Summit. Meeting participants suggested using the International Classification of Functioning (ICF) framework to define the intervention focus for this EGM as well as the outcomes. We further defined the scope of the framework in consultation with our research team which includes input from the public (AL), practitioners (LS, PT, KP, JN, ET, PW), information scientist (MR), policy-makers (RS, HS) and researchers (VW, SM, JTC, MGC, EK, BS, AS, WZ).
The EGM framework will inform the inclusion and exclusion criteria. Key dimensions of the framework are listed below. We will follow the standard EGM framework as a matrix where the rows are intervention domains, and the columns are outcome categories. The interventions and outcomes will have sub-categories.
Maintaining autonomy and independence, especially being able to make their own choices and decisions, are important for older adults in all settings (Hillcoat-Nalletamby, 2014; Plath, 2009; Welford, Murphy, Rodgers, & Frauenlob, 2012) . The concept of home is defined broadly, as the place of dwelling in which older adults seek to maintain their autonomy. This can include residential homes, longterm care facilities, hospices, nursing homes and any non-acute care places of residence. This EGM will identify health and social support services as well as technological interventions that optimize functional ability among older adults by systematically collecting, identifying, and mapping available evidence. In order to reflect the most relevant interventions and outcomes associated with supporting functional ability among older adults, we adapted the ICF framework and (WHO, 2001; Sadana & Posarac, 2018) . The ICF is a comprehensive framework used by the WHO to measure health and disability at both individual and population levels. The WHO is also using the ICF as the basis to operationalize the measurement of intrinsic capacities, functional ability, and enabling environments (Sadana & Posarac, 2018) Given the importance of the home setting in optimizing functional ability in older adults and in consultation with our advisory group, we are interested in technological interventions that support mobility at home (e.g., walking devices, ramps), social care services (e.g., homemaking, personal care) and health care services (e.g., covering promotive, preventive, treatment, rehabilitative, whether long-term, provided by family physician visits or other health workers) delivered in the home setting.
| Stakeholder engagement
We have created an Advisory Group comprised of methodologists, physicians (and other health-care professionals), consumers and researchers with expertize in assistive health technology, healthy ageing, long-term care, rehabilitation, disability, memory, and cognitive impairment. We held an exploratory meeting to invite feedback on the development of our EGM framework at the Global Evidence Summit in Cape Town, September 2017. The participants included family practitioners, geriatricians, social workers, and methodologists. We also held a seminar at the Bruyère Research Institute Grand Rounds (October 26, 2017) with family practitionerresearchers, where participants provided feedback on the intervention-outcome framework. Our decision to focus on the selected WELCH ET AL. | 3 of 12 intervention categories was also informed by public engagement through our public representative (AL). Our central team (VW, TH, SM, PB, and CM) plans to meet at least once a month to discuss the direction and scope of the EGM. Figure 1 below demonstrates the conceptual framework through which the inputs lead to the intended outcomes. A person's intrinsic capacity is dependent on their health characteristics (e.g., healthrelated behaviors, disease, or injuries), genetic inheritance, and personal characteristics (e.g., sex/gender or ethnicity). However, the extent to which an individual accomplishes what they value is also dependent on functional ability and their interactions with the environment, Enabling environments (i.e., services, systems and policies, and products and technology), when implemented within a home context, can influence outcomes such as improved neuromusculoskeletal functioning, through the use of an external aid, assistance by another person or improvement in the built environment. Supportive environments can strongly influence functional ability in the home among older adults. We also included health inequalities as an outcome of interest because we are aware that certain characteristics may stratify or impact health opportunities and outcome, such as socioeconomic status or place of residence.
| Conceptual framework
We will review and update our conceptual framework as we develop the map.
| DIMENSIONS
| Types of study design
We will include randomized trials and systematic reviews of both randomized and nonrandomized trials that meet our inclusion criteria. We define a systematic review according to the PRISMA definition, which encompasses articles that specifically stated methods used to identify studies (i.e., a search strategy), strategies for study selection (e.g., eligibility criteria and selection process) and explicitly detailed methods of synthesis (Moher et al., 2015) . This study design, as defined by PRISMA, uses a transparent and an a priori methodology in order to ensure rigor.
We will exclude systematic reviews of predictive factors, prognostic and diagnostic studies, and studies that primarily analyze implementation, barriers and facilitators to effectiveness (Snilstveit et al., 2013) .
Since the aim of the EGM is to inform priorities for systematic reviews and knowledge exchange activities, we will also include ongoing systematic reviews and randomized trials. We will also include studies published in gray literature such as reports, dissertations, and conference abstracts.
We do not plan to include qualitative research.
| Types of intervention/problem
We will contextualize interventions according to the ICF categorization of environmental factors. This will be further divided into:
1. Products and technology related to mobility: The ICF provides a very comprehensive list of eligible interventions. We will specifically examine section e1201 and e155 from the ICF that comprises assistive products and technology for personal indoor and outdoor mobility and transportation as well as design, construction, and building products and technology of buildings for private use. This includes products such as wheelchairs, walking devices, transfer devices, and ramps.
2. Health and social services, systems and policies: While we recognize that systems and policies can have an impact on the individual, we will specifically focus on sections e5750 and e5800, which includes health and social support services provided at home such as homemaking, personal care, health care professional home visits, or long-term care.
We decided to limit the scope of the ICF framework due to feasibility. Specifically, we will exclude studies of pharmacological interventions, therapies, telemedicine or telecare, educational programs, and any hospital-based programs. We will also exclude any studies that examine caregiver support services exclusively without evaluating outcomes related to older adults. A comprehensive list of interventions in each category may be found in Table 1 .
| Types of population (as applicable)
This EGM will focus on adults over the age of 60 years, using the United Nations cut off for older or elderly individuals (United, 2015) , and particularly those over 75 years of age. Studies and reviews will be included if at least 50% of the sample population is greater than 60 years old.
| Types of outcome measures (as applicable)
We will map the evidence on outcomes that fall into one of the following ICF (WHO, 2001) . adapted categories: impairments to body functions and structures (expressed as intrinsic capacities), and functional ability. We will also include process and other outcomes that may also have an effect on a particular outcome. We will consider health inequities by examining environmental and personal attributes that may stratify health opportunities and outcomes, using the PROGRESS framework . Our outcomes framework is provided in Table 3 .
Intrinsic capacity will consist of mental (e.g., depression, sleep, vitality); sensory functions and pain (e.g., vision, hearing); neuromusculoskeletal function (e.g., gait, balance); voice and speech (e.g., articulation); cardiovascular, hematological, immune, respiratory system function (e.g., blood pressure, respiration); digestive, endocrine, metabolic functions (e.g., thyroid, glucose); genitourinary and reproductive function (e.g., bladder control); and integumentary system function (e.g., skin, nails).
Functional ability will consist of the following constructs: basic needs (e.g., self-care, acquisition of goods and services); learning and applying knowledge (e.g., applying knowledge); contribution (e.g., community life, employment); mobility (e.g., walking); relationships (e.g., interpersonal interactions); and communication (e.g., language). Process and other outcomes will include cost (out of pocket), cost-effectiveness, falls, satisfaction of older adult, safety, caregiver outcomes, adherence, health service utilization, quality of life, financial security, access, and stigma. Access is a multi-faceted concept and can be understood as the opportunity or ease with which consumers or communities are able to use appropriate services in proportion to their needs (Daniels, 1982; Whitehead, 1992) . The concept of access will include: acceptability, approachability, availability and accommodation, affordability and appropriateness (Levesque, Harris Mark, & Russell, 2013) .
We will use the PROGRESS framework to identify studies that measured effects of interventions by gender or other health inequalities.
| Other eligibility criteria
| Types of settings
We will include interventions in the home setting for older adults. We will define home as an individual's place of residence that can include residential homes, apartments, long-term care facilities, hospices, nursing homes and any nonacute care places of residence. Studies of mixed settings will be included as long as the intervention takes place in the home setting at least 50% of the time. We will code the settings so that the evidence can be filtered according to setting.
Acute and sub-acute hospital and convalescent care settings will be excluded (e.g., geriatric rehabilitation in subacute care).
| Search methods and sources
We will develop and pilot a search strategy (with a selection of studies that met our inclusion criteria) with the guidance of an Table 2 for full search strategy.
We will search for relevant trials and systematic reviews in the gray literature via ProQuest Theses and Dissertation Global and via Conference Proceedings Citation Index. We will also search for relevant unpublished studies via relevant international organizations (e.g., Help Age, World Health Organization, and Institute for Research on Public Policy).
Ongoing systematic reviews will be identified by searching for protocols in PROSPERO and the Cochrane and Campbell libraries 
| ANALYSIS AND PRESENTATION
| Report structure
The EGM report will include the following sections: executive summary, background, methods, results, and conclusion. The
Category Terms executive summary will summarize the report, providing the main findings and implications for future policy planning and research. The background will provide a comprehensive description of the burden of illness and disability among aging older adults and the impact on functional ability and state the objectives of the EGM. We will also describe the scope by defining the intervention and outcomes framework, and theory of change (supplemented by a figure) .
Description of the methods will include a definition of the data sources and methods of searching, the inclusion and exclusion criteria, study selection, quality appraisal, and data extraction methods and the approach to presentation/visualization. This section will provide a table
in-text showing one full search from a database as well as a PRISMA flow chart. An appendix will provide full search strategies used for each database, including any restrictions and filters used.
The results section will present the number, type, and quality of studies retrieved for the main intervention categories, namely, products and technology related to mobility, and health and social services at home. We will also present information about how health equity has been considered in studies, provide an overview of major evidence gaps based on our framework, and list any limitations. The conclusion will provide implications for researchers, decision-makers and policymakers on the evidence base in this area and the key areas for the commissioning of future research. We will also include implications for researchers considering conducting an EGM.
Tables and figures we will include:
• Figure: Conceptual map/theory of change.
• Figure: PRISMA flow chartTable: number of studies by study design.
• Table: Number of studies by intervention and subcategories.
• Table: Number of studies by population.
| Filters for presentation
We will present results as a matrix of interventions (rows) and outcomes (columns) and assess the availability of evidence across the additional filters of age groups, conditions, equity categories (i.e., PROGRESS) and setting.
| Dependency
When there are multiple reports for a single study, we will treat them as one study. We acknowledge that SRs are likely to include the RCTs in the map and there may be more than one SR which includes the same RCT. All relevant randomized trials will be included regardless of whether or not it is included in a systematic review.
6 | DATA COLLECTION AND ANALYSIS
| Screening and study selection
Two reviewers will independently screen the titles and abstracts of all retrieved articles. Title and abstracts will be screened on the basis of intervention, study design, and population, and not on the basis of outcome. Full-texts of potentially eligible studies will then be retrieved and screened. The reviewers will compare the results, and any conflicts will be resolved through discussion or by a third reviewer. We will not contact authors of studies or reviews for missing information.
| Data extraction and management
Two reviewers will independently extract data on published and ongoing systematic reviews and randomized trials related to the population, intervention, comparison, and outcomes. Our coding categories (Appendix) for data extraction will be based on our intervention/outcomes framework. In addition, we will collect details on characteristics that may be of interest to decision makers as filters for the evidencethe country of the study (using WHO regions as well as the World Bank country classifications by income), age group (e.g., <65 years, >65 years, etc. ), health conditions (e.g., communicable, noncommunicable), study design (e.g., RCT or systematic review) and setting (e.g., residential home, independent living, assisted living, or long term care).
We will also collect details, if reported, on health equity as defined according to the PROGRESS frameworkplace of residence, race/ethnicity/language/culture, occupation, gender/sex, religion, education, socioeconomic status, social capital and other characteristics associated with disadvantage and vulnerability such as sexual orientation, age and disability . Furthermore, we will examine whether studies assessed the effects of the intervention by gender or any other characteristic of health inequality such as socioeconomic status. For systematic reviews, we will report equity characteristics as described, and will not go back to included primary studies for more details.
| Tools for assessing risk of bias/study quality of included reviews
Since systematic reviews are often used for decision making, we will appraise the quality of systematic reviews with AMSTAR-2 (Shea, Reeves, & Wells, 2017) in duplicate for 10% of eligible studies. Kappa statistics will also be used to check agreement for each item. If the agreement is over 80%, we will proceed with single data extraction with verification by a second reviewer for the remainder of studies.
The quality of randomized trials is not usually assessed in EGMs since the purpose is to identify the randomized trials available, and not to make decisions based on single trials. As such, we will not assess the quality of randomized trials (Snilstveit, Bhatia, Rankin, & Leach, 2017 ).
| Methods for mapping
We plan to use the EPPI-Reviewer 4 software to generate the map (EPPI-Centre, 2019).
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